CompletedNot Applicable

ESBL in Patients Returning to Sweden With Traveller's Diarrhoea

Sweden305 participantsStarted 2017-02-01

Plain-language summary

Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas. This study investigates to what extent travellers returning to Sweden with traveller's diarrhoea carry ESBL in their stool. The isolates are examined further according to species, phenotype, antibiogram and whole genome sequencing.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Travellers diarrhoea * foreign traveller Exclusion Criteria: * foreign traveller but no symptoms

What they're measuring

Proportion ESBL-colonized after one year.

Timeframe: 1 year

Trial details

NCT IDNCT03866291

SponsorLund University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-06-20

View on ClinicalTrials.gov More Antibiotic Resistant Infection trials